Lexology July 26, 2021
Morrison & Foerster LLP

It’s summer blockbuster season and that means sequels abound. Now it seems that the U.S. Congress wants in on the action. Just five years after Congress passed the 21st Century Cures Act, a bipartisan group of representatives is looking to enact follow-up legislation—“Cures 2.0.” Last month, Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) released draft legislation that proposed sweeping policy changes, many of them inspired by the COVID-19 pandemic. If passed into law, the 127-page legislation would affect medical research, health insurance, and FDA regulatory policies; it would even establish a new agency.

This life sciences blog hopes to explain the discussion draft for Cures 2.0. It begins with a quick recap of the first Cures Act, then explains...

Today's Sponsors

Canton & Company

Today's Sponsors

Curation Health

Today's Sponsor


Topics: Congress / White House, Cures Act, Govt Agencies, Regulations
FDA Needs A Competitiveness Czar
The 21st Century Cures Act update: where we've been and where we're going
ONC announces new interoperability program for federal partners
6 Steps for Securing Patient Information in Healthcare
Health Tech Companies Face Penalties for Not Sharing Information